SCHEMBL7091071

SCHEMBL7091071

Cc1nc(N=Nc2cccc(Cl)c2)c(COP(=O)(O)O)c(C=O)c1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 4/20 0.73
P2RY13 Q9BPV8 4/20 0.70
PLA2G2A P14555 1/20 0.70
P2RX7 Q99572 3/20 0.68
YWHAG P61981 1/20 0.68
YWHAZ P63104 1/20 0.68
MAPT P10636 5/20 0.62
TDP1 Q9NUW8 5/20 0.62
KDM4E B2RXH2 3/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
P2RX3 P56373 2/20 0.62
P2RX2 Q9UBL9 2/20 0.62
HPGD P15428 2/20 0.62
HSD17B10 Q99714 2/20 0.62
ALDH1A1 P00352 2/20 0.62
CASP1 P29466 1/20 0.62
CYP2C19 P33261 1/20 0.62
RAB9A P51151 1/20 0.62
CASP7 P55210 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16450978 0.89 MAPT (0.73) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL7095169 0.86 P2RX7 (0.65) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL13961828 0.85 P2RY1 (0.74) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL7096181 0.84 P2RX7 (0.63) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL13962116 0.83 P2RY1 (1.00) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL13962115 0.82 P2RY1 (0.71) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL7094651 0.82 P2RX7 (0.74) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL7094745 0.82 P2RX7 (0.60) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL7091065 0.82 P2RX7 (0.62) P2RY1P2RY13PLA2G2AP2RX7YWHAG
SCHEMBL7092617 0.82 P2RX7 (0.64) P2RY1P2RY13PLA2G2AP2RX7YWHAG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6638921-B1 Pharmaceutically acceptable derivatives thereof Cx, R1 and R2 being as defined in the disclosure may be used to inhibit the activity of HIV integrase. PHARMACOR INC. (CA) 2003-10-28 US disclosed
WO-2003082881-A2 PYRIDOXAL-5-PHOSPHATE DERIVATIVES AS HIV INTEGRASE INHIBITORS PROCYON BIOPHARMA INC. (CA) 2003-10-09 WO disclosed